Markets
S&P 5007,126+1.20%
Nasdaq 10026,672+1.29%
Dow Jones49,447+1.79%
Russell 20002,777+2.11%
EUR/USD1.1755-0.38%
Gold$4813.30-0.91%
WTI$82.59-1.50%
Brent$90.380.00%
UST10 YTM4.25%-1.48%
Markets
S&P 5007,126+1.20%
Nasdaq 10026,672+1.29%
Dow Jones49,447+1.79%
Russell 20002,777+2.11%
EUR/USD1.1755-0.38%
Gold$4813.30-0.91%
WTI$82.59-1.50%
Brent$90.380.00%
UST10 YTM4.25%-1.48%
Ocular Therapeutix, Inc. Common Stock(OCUL)
NASDAQ-GM: OCUL · Real-Time Price · USD
$9.82-0.13 (-1.32%)
Market Cap$2.11B
Revenue (ttm)$51.95M
Net IncomeN/A
EPS$-1.42
Shares Out217.69M
PE RatioN/A
Forward PE-7.82
DividendN/A
Volume1,273
Open$9.82
Previous Close$9.82
Day's Range$9.69 - $9.69
52-Week Range$6.23 - $16.44
Beta0.95
Analystsstrong_buy
Price Target$26.00
About OCUL
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthal...